186 related articles for article (PubMed ID: 37971525)
1. [New treatment options in system therapy for breast carcinoma and associated new side effects].
Landin J; Weber WP; Vetter M
Ther Umsch; 2023 Oct; 80(8):353-358. PubMed ID: 37971525
[TBL] [Abstract][Full Text] [Related]
2. [Adjuvant therapies in breast carcinoma].
Joss R; Brunner K
Schweiz Rundsch Med Prax; 1991 Mar; 80(11):247-54. PubMed ID: 2024099
[TBL] [Abstract][Full Text] [Related]
3. Metastatic breast cancer: understanding current management options.
McGinn K; Moore J
Oncol Nurs Forum; 2001 Apr; 28(3):507-12; quiz 513-4. PubMed ID: 11338758
[TBL] [Abstract][Full Text] [Related]
4. Advances in chemical pharmacotherapy to manage advanced breast cancer.
Gombos A; Awada A
Expert Opin Pharmacother; 2017 Jan; 18(1):95-103. PubMed ID: 27927046
[TBL] [Abstract][Full Text] [Related]
5. Clinical Implications of the Progression-Free Survival Endpoint for Treatment of Hormone Receptor-Positive Advanced Breast Cancer.
Kaklamani VG
Oncologist; 2016 Aug; 21(8):922-30. PubMed ID: 27256875
[TBL] [Abstract][Full Text] [Related]
6. Optimal management of brain metastases from breast cancer. Issues and considerations.
Bartsch R; Berghoff AS; Preusser M
CNS Drugs; 2013 Feb; 27(2):121-34. PubMed ID: 23239265
[TBL] [Abstract][Full Text] [Related]
7. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
8. Metaplastic breast cancer: clinical overview and molecular aberrations for potential targeted therapy.
Abouharb S; Moulder S
Curr Oncol Rep; 2015 Mar; 17(3):431. PubMed ID: 25691085
[TBL] [Abstract][Full Text] [Related]
9. [Taxanes in primary systemic treatment of breast cancer].
von Minckwitz G
Onkologie; 2003 Dec; 26 Suppl 7():21-5. PubMed ID: 14716138
[TBL] [Abstract][Full Text] [Related]
10. [Chinese expert consensus on the clinical diagnosis and treatment of advanced breast carcinoma(2018)].
Chinese Anti-Cancer Association, Committee of Breast Cancer Society
Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):703-713. PubMed ID: 30293398
[TBL] [Abstract][Full Text] [Related]
11. The role of chemotherapy and targeted agents in patients with metastatic breast cancer.
Johnston SR
Eur J Cancer; 2011 Sep; 47 Suppl 3():S38-47. PubMed ID: 21944023
[TBL] [Abstract][Full Text] [Related]
12. [Adjuvant chemotherapy of early stage breast cancer].
Boér K
Orv Hetil; 2010 Feb; 151(9):344-53. PubMed ID: 20159750
[TBL] [Abstract][Full Text] [Related]
13. Surgery for breast cancer.
Dooley WC
Curr Opin Oncol; 1998 Nov; 10(6):504-12. PubMed ID: 9818228
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
[TBL] [Abstract][Full Text] [Related]
15. Brain metastases as site of first and isolated recurrence of breast cancer: the role of systemic therapy after local treatment.
Niwińska A
Clin Exp Metastasis; 2016 Oct; 33(7):677-85. PubMed ID: 27225754
[TBL] [Abstract][Full Text] [Related]
16. Trastuzumab-deruxtecan: an investigational agent for the treatment of HER2-positive breast cancer.
Bartsch R
Expert Opin Investig Drugs; 2020 Sep; 29(9):901-910. PubMed ID: 32701032
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer.
Barrett SV
J R Coll Physicians Edinb; 2010 Dec; 40(4):335-8; quiz 339. PubMed ID: 21132144
[TBL] [Abstract][Full Text] [Related]
18. The St. Gallen Prize Lecture 2011: evolution of long-term adjuvant anti-hormone therapy: consequences and opportunities.
Jordan VC; Obiorah I; Fan P; Kim HR; Ariazi E; Cunliffe H; Brauch H
Breast; 2011 Oct; 20 Suppl 3(Suppl 3):S1-11. PubMed ID: 22015273
[TBL] [Abstract][Full Text] [Related]
19. Brain metastases in HER2-positive breast cancer: the evolving role of lapatinib.
Tomasello G; Bedard PL; de Azambuja E; Lossignol D; Devriendt D; Piccart-Gebhart MJ
Crit Rev Oncol Hematol; 2010 Aug; 75(2):110-21. PubMed ID: 20004109
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant therapy for breast cancer.
Hortobagyi G
Annu Rev Med; 2000; 51():377-92. PubMed ID: 10774471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
